Related references
Note: Only part of the references are listed.BH3 profiling identifies heterogeneous dependency on Bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics
C. Touzeau et al.
LEUKEMIA (2016)
Cell type-dependent ROS and mitophagy response leads to apoptosis or necroptosis in neuroblastoma
F. Radogna et al.
ONCOGENE (2016)
BH3 profiling and a toolkit of BH3-mimetic drugs predict anti-apoptotic dependence of cancer cells
Michael Butterworth et al.
BRITISH JOURNAL OF CANCER (2016)
Directly targeting the mitochondrial pathway of apoptosis for cancer therapy using BH3 mimetics - recent successes, current challenges and future promise
Kristopher A. Sarosiek et al.
FEBS JOURNAL (2016)
Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death
Giampaolo Morciano et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
Joan Montero et al.
CELL (2015)
Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450
C. Cerella et al.
CELL DEATH & DISEASE (2015)
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
J. D. Leverson et al.
CELL DEATH & DISEASE (2015)
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Rongqing Pan et al.
CANCER DISCOVERY (2014)
Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription
Daniel Thomas et al.
BLOOD (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells
Tom Juncker et al.
BIOCHEMICAL PHARMACOLOGY (2011)
BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation
Meike Vogler et al.
BLOOD (2011)
The fast-mobility isoform of mouse Mcl-1 is a mitochondrial matrix-localized protein with attenuated anti-apoptotic activity
Chi-Ruei Huang et al.
FEBS LETTERS (2010)
Apoptosis-based therapies for hematologic malignancies
JC Reed et al.
BLOOD (2005)
Share Paper
